Last $1.25 USD
Change Today -0.01 / -0.79%
Volume 211.3K
VICL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:30 PM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - vical inc (VICL)

Name (Connections)Board RelationshipsTitleKey Developments
Robert Merton Ph.D. 17 RelationshipsDirector and Chairman of Audit Committee 
George Morrow 66 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee 
Richard Beleson 57 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - vical inc (VICL)

Name (Connections)Board RelationshipsTitle
Gary Lyons 32 RelationshipsDirector, Chairman of Nominating/Governance Committee and Member of Compensation Committee
George Morrow 66 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Stephen Sherwin M.D. 168 RelationshipsDirector, Member of Compensation Committee and Member of Nominating/Governance Committee
VICL Compensation vs. Industry
557.0K
363.4K
Chief Executive Officer
Share price activity for VICAL INC (VICL)
52 Week Price Performance
VICL
Industry Average

Nominating Committee* - vical inc (VICL)

Name (Connections)Board RelationshipsTitleKey Developments
R. Douglas Jr., M.D. 63 RelationshipsChairman and Member of Nominating/Governance CommitteeVical Incorporated Announces Board Appointments
05/23/13
Gary Lyons 32 RelationshipsDirector, Chairman of Nominating/Governance Committee and Member of Compensation CommitteeVical Incorporated Announces Management Appointments
04/18/13
Stephen Sherwin M.D. 168 RelationshipsDirector, Member of Compensation Committee and Member of Nominating/Governance CommitteeVical Incorporated Announces Resignation of Jill M. Broadfoot as Senior Vice President, Chief Financial Officer and Secretary, Effective April 1, 2013
03/15/13

Corporate Governance Committee* - vical inc (VICL)

Name (Connections)Board RelationshipsTitle
R. Douglas Jr., M.D. 63 RelationshipsDirector, Chairman of Nominating/Governance Committee and Member of Compensation Committee
Gary Lyons 32 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Stephen Sherwin M.D. 168 RelationshipsDirector, Member of Compensation Committee and Member of Nominating/Governance Committee
VICL and Competitor
Insiders vs. External
Board
14%
86%
Vical Incorporated
17%
83%
GenVec, Inc.
16%
84%
Progenics Pharmaceuticals, Inc.
30%
70%
Dynavax Technologies Corporation
9%
91%
Advaxis, Inc.
20%
80%
Genocea Biosciences, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VICL:US $1.25 USD -0.01

VICL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advaxis Inc $3.15 USD +0.37
Dynavax Technologies Corp $1.41 USD -0.01
Genocea Biosciences Inc $13.35 USD +0.21
GenVec Inc $2.06 USD -0.03
Progenics Pharmaceuticals Inc $5.12 USD -0.06
View Industry Companies
 

Industry Analysis

VICL

Industry Average

Valuation VICL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.5x
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.